Please enable JavaScript to continue using this application.

Compare $PALI vs $ZSQR | Chartloom

Compare

$PALI vs $ZSQR

Palisade Bio Inc · Z Squared Inc (Delaware)

PALI

Palisade Bio Inc

ZSQR

Z Squared Inc (Delaware)

Compare $PALI vs $ZSQR

Comparing Palisade Bio Inc and Z Squared Inc (Delaware)

PALIPalisade Bio Inc

ZSQRZ Squared Inc (Delaware)

PALIPalisade Bio Inc

Market cap

$267M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-38.4%

52W performance

-23.0%

FCF yield

-6.8%

ZSQRZ Squared Inc (Delaware)

Market cap

$298M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

961.0%

YTD performance

-62.8%

52W performance

-62.8%

FCF yield

-1.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

PALI

ZSQR

Detailed metrics comparison

PALI

Palisade Bio Inc

ZSQR

Z Squared Inc (Delaware)

Market Cap

PALI$267M

ZSQR$298M

Enterprise Value

PALI$142M

ZSQR$283M

Price

PALI$1.54

ZSQR$5.66

P/E Ratio

PALIN/A

ZSQRN/A

P/S Ratio

PALI534.63x

ZSQR106.71x

EV/Sales

PALI284.28x

ZSQR101.17x

EV/EBITDA

PALI0.00x

ZSQR0.00x

P/B Ratio

PALI2.06x

ZSQR1.36x

P/FCF Ratio

PALIN/A

ZSQRN/A

EV/FCF

PALI-7.81x

ZSQR-69.99x

PEG Ratio

PALIN/A

ZSQRN/A

Forward P/E (NTM)

PALIN/A

ZSQRN/A

Forward P/S (NTM)

PALIN/A

ZSQRN/A

Revenue (TTM)

PALI$500K

ZSQR$3M

Revenue Growth (YoY)

PALIN/A

ZSQR961.0%

Forward Rev Growth

PALI42864.7%

ZSQR0.0%

Gross Margin (TTM)

PALI0.0%

ZSQR-24.6%

Operating Margin (TTM)

PALI0.0%

ZSQR0.0%

EBITDA Margin (TTM)

PALI-7069.6%

ZSQR-712.5%

Net Margin (TTM)

PALI-6388.2%

ZSQR-785.1%

FCF Margin (TTM)

PALI-3638.0%

ZSQR-144.6%

Net Income (TTM)

PALI$-32M

ZSQR$-22M

FCF (TTM)

PALI$-18M

ZSQR$-4M

EPS (TTM)

PALI-$0.15

ZSQR-$0.44

ROE (TTM)

PALI-3347.0%

ZSQR-5059.0%

ROA (TTM)

PALI-3179.0%

ZSQR-4757.0%

ROIC (TTM)

PALI-3345.0%

ZSQR-5038.0%

Cash

PALI$125M

ZSQR$15M

Debt

PALI$0

ZSQR$0

Net Cash/Debt

PALI$125M

ZSQR$15M

Current Ratio (TTM)

PALI24.26x

ZSQR7.66x

Quick Ratio (TTM)

PALI23.97x

ZSQR7.64x

Debt/Equity (TTM)

PALI0.00x

ZSQR0.02x

Debt/Assets (TTM)

PALI0.0%

ZSQR0.0%

Interest Coverage (TTM)

PALIN/A

ZSQRN/A

Net Debt/EBITDA (TTM)

PALI0.00x

ZSQR0.00x

Beta

PALI1.53

ZSQRN/A

52W Performance

PALI-23.0%

ZSQR-62.8%

YTD Performance

PALI-38.4%

ZSQR-62.8%

% from 52W High

PALI-46.0%

ZSQR-69.9%

% from 52W Low

PALI16.7%

ZSQR168.2%

Asset Turnover (TTM)

PALI0.00x

ZSQR0.06x

FCF Yield (TTM)

PALI-6.8%

ZSQR-1.4%

Earnings Yield (TTM)

PALI-11.9%

ZSQR-7.4%

Dividend Yield (TTM)

PALIN/A

ZSQRN/A

Rule of 40

PALI-3,638.0

ZSQR816.4

EV/GP/RG

PALIN/A

ZSQRN/A

Ticker research

View PALI research View ZSQR research

Metric	PALI Palisade Bio Inc	ZSQR Z Squared Inc (Delaware)
Market & Valuation
Market Cap	$267M	$298M
Enterprise Value	$142M	$283M
Price	$1.54	$5.66
P/E Ratio	N/A	N/A
P/S Ratio	534.63x	106.71x
EV/Sales	284.28x	101.17x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.06x	1.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.81x	-69.99x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$500K	$3M
Revenue Growth (YoY)	N/A	961.0%
Forward Rev Growth	42864.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	-24.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7069.6%	-712.5%
Net Margin (TTM)	-6388.2%	-785.1%
FCF Margin (TTM)	-3638.0%	-144.6%
Net Income (TTM)	$-32M	$-22M
FCF (TTM)	$-18M	$-4M
EPS (TTM)	-$0.15	-$0.44
ROE (TTM)	-3347.0%	-5059.0%
ROA (TTM)	-3179.0%	-4757.0%
ROIC (TTM)	-3345.0%	-5038.0%
Financial Health
Cash	$125M	$15M
Debt	$0	$0
Net Cash/Debt	$125M	$15M
Current Ratio (TTM)	24.26x	7.66x
Quick Ratio (TTM)	23.97x	7.64x
Debt/Equity (TTM)	0.00x	0.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.53	N/A
52W Performance	-23.0%	-62.8%
YTD Performance	-38.4%	-62.8%
% from 52W High	-46.0%	-69.9%
% from 52W Low	16.7%	168.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.06x
FCF Yield (TTM)	-6.8%	-1.4%
Earnings Yield (TTM)	-11.9%	-7.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,638.0	816.4
EV/GP/RG	N/A	N/A
Ticker research	View PALI research	View ZSQR research

Valuation

P/S Ratio

ZSQR

106.71x

PALI

534.63x

EV/FCF

ZSQR

-69.99x

PALI

-7.81x

Growth & revenue

Revenue Growth TTM

ZSQR

961.0%

Forward Revenue Growth

PALI

42864.7%

ZSQR

0.0%

Profitability & performance

Gross Margin

PALI

0.0%

ZSQR

-24.6%

ROE

PALI

-3347.0%

ZSQR

-5059.0%

FCF Yield %

ZSQR

-1.4%

PALI

-6.8%

52-Week Performance

PALI

-23.0%

ZSQR

-62.8%

Detailed metrics comparison

PALI

Palisade Bio Inc

ZSQR

Z Squared Inc (Delaware)

Market Cap

PALI$267M

ZSQR$298M

Enterprise Value

PALI$142M

ZSQR$283M

Price

PALI$1.54

ZSQR$5.66

P/E Ratio

PALIN/A

ZSQRN/A

P/S Ratio

PALI534.63x

ZSQR106.71x

EV/Sales

PALI284.28x

ZSQR101.17x

EV/EBITDA

PALI0.00x

ZSQR0.00x

P/B Ratio

PALI2.06x

ZSQR1.36x

P/FCF Ratio

PALIN/A

ZSQRN/A

EV/FCF

PALI-7.81x

ZSQR-69.99x

PEG Ratio

PALIN/A

ZSQRN/A

Forward P/E (NTM)

PALIN/A

ZSQRN/A

Forward P/S (NTM)

PALIN/A

ZSQRN/A

Revenue (TTM)

PALI$500K

ZSQR$3M

Revenue Growth (YoY)

PALIN/A

ZSQR961.0%

Forward Rev Growth

PALI42864.7%

ZSQR0.0%

Gross Margin (TTM)

PALI0.0%

ZSQR-24.6%

Operating Margin (TTM)

PALI0.0%

ZSQR0.0%

EBITDA Margin (TTM)

PALI-7069.6%

ZSQR-712.5%

Net Margin (TTM)

PALI-6388.2%

ZSQR-785.1%

FCF Margin (TTM)

PALI-3638.0%

ZSQR-144.6%

Net Income (TTM)

PALI$-32M

ZSQR$-22M

FCF (TTM)

PALI$-18M

ZSQR$-4M

EPS (TTM)

PALI-$0.15

ZSQR-$0.44

ROE (TTM)

PALI-3347.0%

ZSQR-5059.0%

ROA (TTM)

PALI-3179.0%

ZSQR-4757.0%

ROIC (TTM)

PALI-3345.0%

ZSQR-5038.0%

Cash

PALI$125M

ZSQR$15M

Debt

PALI$0

ZSQR$0

Net Cash/Debt

PALI$125M

ZSQR$15M

Current Ratio (TTM)

PALI24.26x

ZSQR7.66x

Quick Ratio (TTM)

PALI23.97x

ZSQR7.64x

Debt/Equity (TTM)

PALI0.00x

ZSQR0.02x

Debt/Assets (TTM)

PALI0.0%

ZSQR0.0%

Interest Coverage (TTM)

PALIN/A

ZSQRN/A

Net Debt/EBITDA (TTM)

PALI0.00x

ZSQR0.00x

Beta

PALI1.53

ZSQRN/A

52W Performance

PALI-23.0%

ZSQR-62.8%

YTD Performance

PALI-38.4%

ZSQR-62.8%

% from 52W High

PALI-46.0%

ZSQR-69.9%

% from 52W Low

PALI16.7%

ZSQR168.2%

Asset Turnover (TTM)

PALI0.00x

ZSQR0.06x

FCF Yield (TTM)

PALI-6.8%

ZSQR-1.4%

Earnings Yield (TTM)

PALI-11.9%

ZSQR-7.4%

Dividend Yield (TTM)

PALIN/A

ZSQRN/A

Rule of 40

PALI-3,638.0

ZSQR816.4

EV/GP/RG

PALIN/A

ZSQRN/A

Ticker research

View PALI research View ZSQR research

Metric	PALI Palisade Bio Inc	ZSQR Z Squared Inc (Delaware)
Market & Valuation
Market Cap	$267M	$298M
Enterprise Value	$142M	$283M
Price	$1.54	$5.66
P/E Ratio	N/A	N/A
P/S Ratio	534.63x	106.71x
EV/Sales	284.28x	101.17x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.06x	1.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.81x	-69.99x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$500K	$3M
Revenue Growth (YoY)	N/A	961.0%
Forward Rev Growth	42864.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	-24.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7069.6%	-712.5%
Net Margin (TTM)	-6388.2%	-785.1%
FCF Margin (TTM)	-3638.0%	-144.6%
Net Income (TTM)	$-32M	$-22M
FCF (TTM)	$-18M	$-4M
EPS (TTM)	-$0.15	-$0.44
ROE (TTM)	-3347.0%	-5059.0%
ROA (TTM)	-3179.0%	-4757.0%
ROIC (TTM)	-3345.0%	-5038.0%
Financial Health
Cash	$125M	$15M
Debt	$0	$0
Net Cash/Debt	$125M	$15M
Current Ratio (TTM)	24.26x	7.66x
Quick Ratio (TTM)	23.97x	7.64x
Debt/Equity (TTM)	0.00x	0.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.53	N/A
52W Performance	-23.0%	-62.8%
YTD Performance	-38.4%	-62.8%
% from 52W High	-46.0%	-69.9%
% from 52W Low	16.7%	168.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.06x
FCF Yield (TTM)	-6.8%	-1.4%
Earnings Yield (TTM)	-11.9%	-7.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,638.0	816.4
EV/GP/RG	N/A	N/A
Ticker research	View PALI research	View ZSQR research